期刊文献+

40岁以下妇女卵巢上皮性癌73例临床分析 被引量:1

下载PDF
导出
摘要 目的 探讨40岁以下妇女卵巢上皮性癌的临床、病理特点及预后。方法 回顾性分析我院1991年1月-2000年12月期间收治的40岁以下妇女卵巢上皮性癌73例患者的临床资料。结果 73例患者确诊为卵巢上皮性癌的中位平均年龄为33岁,多以腹痛,腹胀和盆腔包块为主要症状,49例(67.1%)为单侧,肿瘤最大径线平均为15.4cm,所有患者均接受肿瘤减灭术,57例(78.1%)达到理想的肿瘤细胞减灭术,病理分级为G1、G2、G3级者分别为45.2%(33/73)、34.2%o(25/73)、20.6%(15/73)。病理类型以浆液性囊腺癌和粘液性囊腺癌最常见,占78.1%(57/73)。41例(56.2%)临床分期为Ⅰ期和Ⅱ期。所有患者均接受了化疗,5年生存率53.4%。本病预后与临床分期、细胞学分级、手术彻底性有良好的相关性。结论 40岁以下妇女患者卵巢上皮性癌较少见,肿瘤体积较大,单侧多见,早期,高分化多见,经手术和化疗,预后相对较好。
出处 《江苏医药》 CAS CSCD 北大核心 2006年第12期1156-1157,共2页 Jiangsu Medical Journal
  • 相关文献

参考文献5

  • 1Yancik R.Ovarian cancer:age contrasts in incidence,histology,disease stage at diagnosis,and mortality.Cancer,1993,71 (Suppl2):517-523.
  • 2Rodriguez M,Nguyen HN,Averette HE,et al.National survey of ovarian carcinoma Ⅻ:epithelial ovarian malignancies in women less than or equal to 25 years of age.Cancer,1994,73:1245-1250.
  • 3Duska LR,Chang YC,Flynn CE,et al.Epithelial ovarian carcinoma in the reproductive age group.Cancer,1999,85:2623-2629.
  • 4Tsai JY,Saigo PE,Browm C,et al.Diagnosis,pathology,staging,treatment,and outcome of epithelial ovarian meoplasia in patients age <21 years.Cancer,2001,91:2065-2070.
  • 5Le T,Krepart GV,Lotocki RJ,et al.Clinically apparent early stage invasive epithelial ovarian carcinoma:should all be treated similarly? Gynecol Oncol,1999,74:252-254.

同被引文献7

  • 1Whitehouse C, Solomon Eo Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening [J]. Gynecol Oncol, 2003, 88(1Pt 2): S152-S157.
  • 2Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomised controlled trial[J]. Lancet, 1999,353(9160) : 1207 -1210.
  • 3van den Heuvel-Eibrink MM, Sonneveld P, Pieters R. The prognostic significance of membrane transport-associated mul tidrug resistance (MDR) proteins in leukemia[J]. Int J Clin Pharmacol Ther, 2000,38 (3) : 94-110.
  • 4Takano M, Kudo K, Goto T, et al. Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer[J].Hum Cell, 2001,14(4) : 267-271.
  • 5Varadi A, Szakacs G, Bakos E, et al. P glycoprotein and the mechanism of multidrug resistance[J]. Novartis Found Syrup, 2002, 243(1):54-65.
  • 6Ozalp SS, Yalcin OT, Tanir M, et al. Multidrug resistance gene-1 (Pgp) expression in epithelial ovarian malignancies[J]. Eur J Gynaecol Oneol, 2002,23(4) : 337-340.
  • 7齐为民,王友臣,程爱生,张晓敏.CA_(125)及其半衰期对卵巢癌诊断与监测的评价[J].细胞与分子免疫学杂志,1999,15(1):40-42. 被引量:5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部